141100-79-0

Basic information

• Product Name: trimethyl-[2-[(2R,3S,4R,5R,6R)-3,4,5-tribenzyloxy-6-(benzyloxymethyl)tetrahydropyran-2-yl]ethynyl]silane
• Synonyms: trimethyl-[2-[(2R,3S,4R,5R,6R)-3,4,5-tribenzyloxy-6-(benzyloxymethyl)tetrahydropyran-2-yl]ethynyl]silane
• CAS NO: 141100-79-0
• Molecular Weight: 620.861
• Mol File: 141100-79-0.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: trimethyl-[2-[(2R,3S,4R,5R,6R)-3,4,5-tribenzyloxy-6-(benzyloxymethyl)tetrahydropyran-2-yl]ethynyl]silane(CAS DataBase Reference)
• NIST Chemistry Reference: trimethyl-[2-[(2R,3S,4R,5R,6R)-3,4,5-tribenzyloxy-6-(benzyloxymethyl)tetrahydropyran-2-yl]ethynyl]silane(141100-79-0)
• EPA Substance Registry System: trimethyl-[2-[(2R,3S,4R,5R,6R)-3,4,5-tribenzyloxy-6-(benzyloxymethyl)tetrahydropyran-2-yl]ethynyl]silane(141100-79-0)

Safety Data

• Hazardous Substances Data: 141100-79-0(Hazardous Substances Data)

Upstream product

• 59531-24-7 2,3,4,6-tetra-O-benzyl-D-glucopyranoside 
• 56822-48-1 (2S,3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-yl acetate 
• 81353-38-0 (trimethylsilylethynyl)tributyltin 
• 4291-69-4 2,3,4,6-Tetra-O-benzyl-D-glucopyranose 
• 78153-79-4 2,3,4,6-tetra-O-benzyl-D-glucopyranosyl fluoride 
• 56822-49-2 1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranoside 
• 80300-30-7 1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose 
• 4196-35-4 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl bromide 
• 82731-79-1 diethyl[(trimethylsilyl)acetylenyl]aluminum 
• 993-07-7 trimethylsilan 
• 6207-45-0 2-(allyloxy)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)-tetrahydro-2H-pyran 
• 168336-52-5 C₃₉H₄₄O₆Si 
• 54655-07-1 lithium trimethylsilylacetylenide 
• 13096-62-3 (3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-one 

Downstream Products

• 1355034-73-9 C₂₃H₂₇N₃O₉ 
• 1355034-75-1 C₂₄H₂₉N₃O₉ 
• 1355034-77-3 C₂₃H₂₆ClN₃O₉ 
• 1355034-79-5 C₂₄H₂₆F₃N₃O₉ 
• 1355034-83-1 C₂₃H₂₆FN₃O₉ 
• 1355034-85-3 C₂₄H₂₉N₃O₁₀ 
• 1355034-89-7 C₂₃H₂₆N₄O₁₁ 
• 1355034-91-1 C₂₄H₂₆N₄O₉ 
• 1355034-97-7 C₂₇H₂₈FN₃O₉S 
• 1355034-74-0 C₁₅H₁₉N₃O₅ 
• 1355034-76-2 C₁₆H₂₁N₃O₅ 
• 1355034-78-4 C₁₅H₁₈ClN₃O₅ 
• 1355034-80-8 C₁₆H₁₈F₃N₃O₅ 
• 1355034-84-2 C₁₅H₁₈FN₃O₅ 

Relevant articles and documents

ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

The invention relates to anti-CD98 antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I). The invention also provides pharmaceutically acceptable compositions containing the compounds and methods of using the compositions in the treatment of bacteria infections. Finally, the invention provides processes for making compounds of the invention.

Total synthesis of indole-3-acetonitrile-4-methoxy-2-C-β-d- glucopyranoside. Proposal for structural revision of the natural product

Indole-3-acetonitrile-4-methoxy-2-C-β-d-glucopyranoside (1), a novel C-glycoside from Isatis indigotica with important cytotoxic activity, has been prepared in ten steps from ethynyl-β-C-glycoside 3 and 2-iodo-3-nitrophenyl acetate 6. Key steps in the synthesis include a Sonogashira coupling and a CuI-mediated indole formation. NMR spectroscopic data for synthetic 1 differs from that reported for the natural product. A revised structure for the natural product, containing an alternate carbohydrate substituent, is proposed. The Royal Society of Chemistry 2012.